Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Impax Laboratories Inc (NASDAQ:IPXL)

32.08
BATS BZX Real-Time Price
As of 1:34pm ET
 -1.52 / -4.52%
Today’s Change
29.66
Today|||52-Week Range
51.42
-24.98%
Year-to-Date

Today’s Trading

Previous close33.60
Today’s open33.33
Day’s range32.02 - 33.33
Volume19,917
Average volume (3 months)691,348
Market cap$2.4B
Dividend yield--
Data as of 1:34pm ET, 05/04/2016

Growth & Valuation

Earnings growth (last year)-33.33%
Earnings growth (this year)+21.33%
Earnings growth (next 5 years)+19.00%
Revenue growth (last year)+44.36%
P/E ratio59.5
Price/Sales3.58
Price/Book2.27

Competitors

 Today’s
change
Today’s
% change
HZNPHorizon Pharma PLC-0.54-3.55%
MDCOMedicines Co-1.48-4.11%
LGNDLigand Pharmaceutica...-0.70-0.58%
MYGNMyriad Genetics Inc-2.09-5.78%
Data as of 1:36pm ET, 05/04/2016

Financials

Next reporting dateMay 10, 2016
EPS forecast (this quarter)$0.39
Annual revenue (last year)$860.5M
Annual profit (last year)$39.0M
Net profit margin4.53%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
George Frederick Wilkinson
Senior Vice President-
Global Operations
Andrew Schaschl
Corporate headquarters
Hayward, California

Forecasts

Partner Offers

Search for Jobs